ACSL4 and renal cell carcinoma: In renal cell carcinoma cells, receptor protein AIM2 promotes FOXO3a phosphorylation and proteasome degradation, thereby abating its transcriptional effect on ACSL4 and inhibiting ferroptosis [37].